Daclizumab [clinicaltrials_resource:b0851cd3d2e4def8df6e679e8bcce91a]
intervention [clinicaltrials_vocabulary:intervention]
Daclizumab [clinicaltrials_resource:b0851cd3d2e4def8df6e679e8bcce91a]
Bio2RDF identifier
b0851cd3d2e4def8df6e679e8bcce91a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b0851cd3d2e4def8df6e679e8bcce91a
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Daclizumab, 1mg/kg of body weight, every 2 weeks for a total of 5 infusions.
intervention name [clinicaltrials_vocabulary:intervention-name]
Daclizumab
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:b0851cd3d2e4def8df6e679e8bcce91a
title
Daclizumab
@en
type
label
Daclizumab [clinicaltrials_resource:b0851cd3d2e4def8df6e679e8bcce91a]
@en